نتائج البحث 181-190 من 3557 لعملية البحث عن Substance+dependence
Currently, most drug-related cancer care is conducted in clinic type centers or hospitals which may isolate patients from family, friends and familiar ...
Venetoclax is FDA approved for the treatment of CLL and SLL. The drug combination of acalabrutinib, durvalumab, and venetoclax is experimental and isn't ...
The purpose of this study is to establish an opioid and multiple addiction (OMA) biobank that creates a comprehensive standard patient phenotype using ...
Canadian Centre on Substance Use and Addiction. https://www.ccsa.ca/canadas-guidance-alcohol-and-health. Accessed Jan. 9, 2024. Science around moderate ...
Accessed March 14, 2023. Mixing medications and dietary supplements can endanger your health. U.S. Food and Drug Administration. https://www.fda.gov/consumers/ ...
The purpose of this study is to determine if a new drug combination, pirtobrutinib and venetoclax, will help Chronic Lymphocytic Leukemia (CLL) or Small ...
The goal of this clinical trial is to learn about the safety of drug \[Ac225\]RTX-2358 and the diagnostic imaging agent \[Cu64\]LNTH-1363S.
Ambien: Is dependence a concern? Amputation and diabetes · Amyloidosis · Anaphylaxis · Anaphylaxis: First aid · Anemia · Angina · Anorexia nervosa · Anthrax ...
... drug alone in treating patients with LMS. ... Jacksonville, Fla. This study is researching an experimental drug called ubamatamab, also referred to as "study drug ...
... dependent phosphate transport protein 2b (NaPi2b) expressing platinum-resistant high-grade serous ovarian cancer (HGSOC), including cancers of ovarian ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.